Bleeding risk with ischemic stroke therapy - Reply
Repository Usage Stats
SubjectScience & Technology
Life Sciences & Biomedicine
Medicine, General & Internal
General & Internal Medicine
Published Version (Please cite this version)10.1001/2012.jama.11667
Publication InfoXian, Y; Liang, L; & Peterson, ED (2012). Bleeding risk with ischemic stroke therapy - Reply. JAMA - Journal of the American Medical Association, 308(13). pp. 1319-1320. 10.1001/2012.jama.11667. Retrieved from https://hdl.handle.net/10161/21643.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
More InfoShow full item record
Eric David Peterson
Fred Cobb, M.D. Distinguished Professor of Medicine
Dr Peterson is the Fred Cobb Distinguished Professor of Medicine in the Division of Cardiology, a DukeMed Scholar, and the Past Executive Director of the Duke Clinical Research Institute (DCRI), Durham, NC, USA. Dr Peterson is the Principal Investigator of the National Institute of Health, Lung and Blood Institute (NHLBI) Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction (SPIRRIT) Trial He is also the Principal I
This author no longer has a Scholars@Duke profile, so the information shown here reflects their Duke status at the time this item was deposited.
Adjunct Associate Professor in the Department of Neurology
Alphabetical list of authors with Scholars@Duke profiles.
Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info